These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31016626)

  • 21. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Helicobacter pylori infection 2013.
    O'Connor A; Molina-Infante J; Gisbert JP; O'Morain C
    Helicobacter; 2013 Sep; 18 Suppl 1():58-65. PubMed ID: 24011247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Helicobacter pylori infection: Where are we now?
    Liou JM; Wu MS; Lin JT
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1918-1926. PubMed ID: 27088632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of current diagnostic methods and advances in
    Pohl D; Keller PM; Bordier V; Wagner K
    World J Gastroenterol; 2019 Aug; 25(32):4629-4660. PubMed ID: 31528091
    [No Abstract]   [Full Text] [Related]  

  • 26. Helicobacter pylori treatment: Still a work in progress.
    Senatore FJ; Wilmot J; Birk JW
    Postgrad Med; 2016 Jan; 128(1):152-7. PubMed ID: 26490697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies.
    Gisbert JP; McNicholl AG
    Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28464347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ERADICATION THERAPY OF HELICOBACTER PYLORI: PRESENT AND FUTURE.
    Safina DD; Abdulkhakov SR; Abdulkhakov RA
    Eksp Klin Gastroenterol; 2016; (11):84-93. PubMed ID: 29889451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological considerations and step-by-step proposal for the treatment of Helicobacter pylori infection in the year 2018.
    Pellicano R; Zagari RM; Zhang S; Saracco GM; Moss SF
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):310-321. PubMed ID: 29600697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori drug resistance: therapy changes and challenges.
    Flores-Treviño S; Mendoza-Olazarán S; Bocanegra-Ibarias P; Maldonado-Garza HJ; Garza-González E
    Expert Rev Gastroenterol Hepatol; 2018 Aug; 12(8):819-827. PubMed ID: 29976092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori-related diseases.
    Gisbert JP
    Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():36-46. PubMed ID: 27888863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of Helicobacter pylori infection 2014.
    O'Connor A; Vaira D; Gisbert JP; O'Morain C
    Helicobacter; 2014 Sep; 19 Suppl 1():38-45. PubMed ID: 25167944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is antimicrobial susceptibility testing necessary before first-line treatment for Helicobacter pylori infection? Meta-analysis of randomized controlled trials.
    Wenzhen Y; Yumin L; Quanlin G; Kehu Y; Lei J; Donghai W; Lijuan Y
    Intern Med; 2010; 49(12):1103-9. PubMed ID: 20558925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Rescue' therapies for the management of Helicobacter pylori infection.
    Di Mario F; Cavallaro LG; Scarpignato C
    Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence-based recommendations for successful Helicobacter pylori treatment.
    Wu JY; Liou JM; Graham DY
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):21-8. PubMed ID: 24410470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of Helicobacter pylori infection 2017.
    O'Connor A; Lamarque D; Gisbert JP; O'Morain C
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori.
    Malfertheiner P; Selgrad M
    Curr Opin Gastroenterol; 2014 Nov; 30(6):589-95. PubMed ID: 25268839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ideal treatment for Helicobacter pylori: a systematic review].
    Sierra F; Forero JD; Rey M
    Rev Gastroenterol Mex; 2014; 79(1):28-49. PubMed ID: 24365458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current options for the treatment of Helicobacter pylori.
    Georgopoulos SD; Papastergiou V; Karatapanis S
    Expert Opin Pharmacother; 2013 Feb; 14(2):211-23. PubMed ID: 23331077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.